Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ginkgolide meglumine injection–midazolam pharmacokinetics interaction study
CTR20140903Phase 4Completed
- Sponsor
- Jiangsu Kanion Pharmaceutical Co., Ltd.
- Start
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Ginkgo diterpene lactone meglumine in brain infarction, sponsored by Jiangsu Kanion Pharmaceutical Co., Ltd.. Started Apr 2015; status: completed.
02
Drugs
Ginkgo diterpene lactone meglumine
03
Conditions
brain infarction
Beyond the preview
Go deeper on CTR20140903.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140903.